Literature DB >> 33232580

Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.

Qi Zhang1, Lin Sun1, Qiuju Zhang1, Wei Zhang1, Wei Tian1, Meina Liu1, Yupeng Wang1.   

Abstract

Hepatocellular carcinoma (HCC) is a heterogeneous malignancy with a high incidence and poor prognosis. Exploration of the underlying mechanisms and effective prognostic indicators is conducive to clinical management and optimization of treatment. The RNA-seq and clinical phenotype data of HCC were retrieved from The Cancer Genome Atlas (TCGA), and differential expression analysis was performed. Then, a differential lncRNA-miRNA-mRNA regulatory network was constructed, and the key genes were further identified and validated. By integrating this network with the online tool-based ceRNA network, an HCC-specific ceRNA network was obtained, and lncRNA-miRNA-mRNA regulatory axes were extracted. RNAs associated with prognosis were further obtained, and multivariate Cox regression models were established to identify the prognostic signature and nomogram. As a result, 198 DElncRNAs, 120 DEmiRNAs, and 2827 DEmRNAs were identified, and 30 key genes identified from the differential network were enriched in four cancer-related pathways. Four HCC-specific lncRNA-miRNA-mRNA regulatory axes were extracted, and SNHG11, CRNDE, MYLK-AS1, E2F3, and CHEK1 were found to be related with HCC prognosis. Multivariate Cox regression analysis identified a prognostic signature, comprised of CRNDE, MYLK-AS1, and CHEK1, for overall survival (OS) of HCC. A nomogram comprising the prognostic signature and pathological stage was established and showed some net clinical benefits. The AUC of the prognostic signature and nomogram for 1-year, 3-year, and 5-year survival was 0.777 (0.657-0.865), 0.722 (0.640-0.848), and 0.630 (0.528-0.823), and 0.751 (0.664-0.870), 0.773 (0.707-0.849), and 0.734 (0.638-0.845), respectively. These results provided clues for the study of potential biomarkers and therapeutic targets for HCC. In addition, the obtained 30 key genes and 4 regulatory axes might also help elucidate the underlying mechanism of HCC.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CeRNA network; differential network analysis; hepatocellular carcinoma; nomogram; prognostic signature

Mesh:

Substances:

Year:  2020        PMID: 33232580      PMCID: PMC7774738          DOI: 10.1002/cam4.3526

Source DB:  PubMed          Journal:  Cancer Med        ISSN: 2045-7634            Impact factor:   4.452


  58 in total

1.  Inference of regulatory networks from microarray data with R and the bioconductor package qpgraph.

Authors:  Robert Castelo; Alberto Roverato
Journal:  Methods Mol Biol       Date:  2012

2.  Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.

Authors:  Jiaxiang Ye; Jinyan Zhang; Yufeng Lv; Jiazhang Wei; Xiaoyun Shen; Junqi Huang; Susu Wu; Xiaoling Luo
Journal:  J Cell Biochem       Date:  2019-04-15       Impact factor: 4.429

3.  LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway.

Authors:  Jinghui Yang; Chunsheng Li; Hang Li; Changyong E
Journal:  J Cell Physiol       Date:  2019-03-25       Impact factor: 6.384

4.  Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function.

Authors:  D Chen; Z Zhang; M Li; W Wang; Y Li; E R Rayburn; D L Hill; H Wang; R Zhang
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

Review 5.  Ribosomal Proteins Control Tumor Suppressor Pathways in Response to Nucleolar Stress.

Authors:  Frédéric Lessard; Léa Brakier-Gingras; Gerardo Ferbeyre
Journal:  Bioessays       Date:  2019-02-01       Impact factor: 4.345

6.  A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth.

Authors:  Michael Wanzel; Annika C Russ; Daniela Kleine-Kohlbrecher; Emanuela Colombo; Pier-Guiseppe Pelicci; Martin Eilers
Journal:  Nat Cell Biol       Date:  2008-09       Impact factor: 28.824

Review 7.  Mechanisms and functions of cellular senescence.

Authors:  Nicolás Herranz; Jesús Gil
Journal:  J Clin Invest       Date:  2018-04-02       Impact factor: 14.808

8.  Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator.

Authors:  X Xiong; Y Zhao; H He; Y Sun
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

9.  Long non-coding RNA-CRNDE: a novel regulator of tumor growth and angiogenesis in hepatoblastoma.

Authors:  Rui Dong; Xiang-Qi Liu; Bin-Bin Zhang; Bai-Hui Liu; Shan Zheng; Kui-Ran Dong
Journal:  Oncotarget       Date:  2017-06-27

10.  Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells.

Authors:  Yu-Hsuan Hung; Hau-Lun Huang; Wei-Ching Chen; Meng-Chi Yen; Chien-Yu Cho; Tzu-Yang Weng; Chih-Yang Wang; Yi-Ling Chen; Li-Tzong Chen; Ming-Derg Lai
Journal:  Oncol Rep       Date:  2016-12-23       Impact factor: 3.906

View more
  6 in total

1.  Integrated Analysis of ceRNA Network to Reveal Potential Prognostic Biomarkers for Glioblastoma.

Authors:  Ruifei Liu; Zhengzheng Gao; Qiwei Li; Qiang Fu; Dongwei Han; Jixi Wang; Ji Li; Ying Guo; Yuchen Shi
Journal:  Front Genet       Date:  2022-02-14       Impact factor: 4.599

2.  Long non-coding RNA X-inactive specific transcript suppresses the progression of hepatocellular carcinoma through microRNA-221-3p-targeted regulation of O6-methylguanine-DNA methyltransferase.

Authors:  Zushun Chen; Lunan Qi; Hongyuan Fu; Liang Ma
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Linc00467 promotes invasion and inhibits apoptosis of head and neck squamous cell carcinoma by regulating miR-1285-3p/TFAP2A.

Authors:  Ying Liang; Gang Cheng; Denggao Huang; Feng Yuan
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.

Authors:  Qi Zhang; Lin Sun; Qiuju Zhang; Wei Zhang; Wei Tian; Meina Liu; Yupeng Wang
Journal:  Cancer Med       Date:  2020-11-24       Impact factor: 4.452

5.  Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study.

Authors:  Zhikun Liu; Yuanpeng Liu; Wenhui Zhang; Yuan Hong; Jinwen Meng; Jianguo Wang; Shusen Zheng; Xiao Xu
Journal:  Hepatol Int       Date:  2022-03-29       Impact factor: 9.029

6.  Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma.

Authors:  Lishi Shao; Lei Liang; Qixiang Fang; Jiaping Wang
Journal:  Heliyon       Date:  2022-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.